Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $223.4 million.

  • Harmony Biosciences Holdings' Total Current Liabilities rose 3851.96% to $223.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.4 million, marking a year-over-year increase of 3851.96%. This contributed to the annual value of $175.1 million for FY2024, which is 690.01% up from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Total Current Liabilities stood at $223.4 million for Q3 2025, which was up 3851.96% from $180.1 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Total Current Liabilities peaked at $223.4 million during Q3 2025, and registered a low of $33.4 million during Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $107.4 million (2022), whereas its average is $113.2 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Total Current Liabilities crashed by 6003.02% in 2021, and later skyrocketed by 12543.1% in 2022.
  • Harmony Biosciences Holdings' Total Current Liabilities (Quarter) stood at $53.8 million in 2021, then surged by 46.69% to $78.9 million in 2022, then skyrocketed by 107.62% to $163.8 million in 2023, then grew by 6.9% to $175.1 million in 2024, then grew by 27.6% to $223.4 million in 2025.
  • Its Total Current Liabilities was $223.4 million in Q3 2025, compared to $180.1 million in Q2 2025 and $175.1 million in Q1 2025.